In the case of hypocalcaemia, omeprazole may interfere with the acidified environment of bone resorption lacunae, causing inactivation of lysosomal enzymes such as tartrate-resistant acid phosphatase (TRAP), thereby slowing down bone matrix degradation and bone resorption processes [49]. The gene discussed is ACP5; the disease is Hypocalcemia.